Antimicrobial resistance (AMR) poses a significant global health threat, primarily stemming from its misuse and overuse in both veterinary and public healthcare systems. The consequences of AMR are severe, leading to more severe infections, increased health protection costs, prolonged hospital stays, un...
Looking at the growth of the POC market in India, a leading pharma player such as Cipla is showing keen interest in this area and started making investments in. Cipla has acquired 21.05 per cent stake (on a fully diluted basis) for Rs 25 crore in Achira Labs. The pharma major said that...
The aggregate market value of the voting stock held by non-affiliates of the registrant as of June 30, 2004, was approximately $1.9 billion. As of February 18, 2005, 161,161,254 shares of the registrant's common stock were outstanding. DOCUMENTS INCORPORATED BY REFERENCE Part III of this ...
AMRFAccès Multiple à Répartition en Fréquence AMRFAlaskan Malamute Research Foundation AMRFAccess to Major Research Facilities AMRFAudie Murphy Research Foundation AMRFAfrican Medical and Research Foundation AMRFAustralian Market Regulatiory Feed(trading)...
"In S. Korea, we aided the National Cancer Center in overcoming labor shortages by augmenting 24/7 hospital staff services. Use cases included food delivery, medication administration, surgical materials transport, infectious waste removal, and sanitization," said Kim. "With Samsung C&T, our units...
The current administration favors a weaker dollar as a strategy for boosting domestic manufacturing. Wayne DugganMarch 17, 2025 9 Defensive ETFs for a Volatile Market These defensive ETFs can weather the ups and downs of a choppy market better than others. ...
Food and Drug Administration (FDA), and the Japanese Pharmaceutical and Medical Device Agency (PMDA) agreed on common regulatory approaches and clinical trial design for antibiotics. The tripartite agreement aims to align on requirements for the clinical development of antibiotics and reduce the time ...
The AMR Action Fund is an initiative of more than 20 leading biopharmaceutical companies that have pledged to invest nearly $ 1 billion, with the goal of bringing 2 to 4 new antibiotics to market by 2030. Use the CB Insights Platform to explore AMR Actio
Amsterdam, 30 November 2020:A new report from CPhI explores the potential implications in 2021 of impending vaccine approvals, a new administration in the White House and a return to dual supply chain strategies. The report – which summarises expert analysis into 12 key findings – fore...
Safety considerations are becoming increasingly paramount in industrial operations, driving the adoption of AMRs as alternatives to traditional material handling equipment. According to the Occupational Safety and Health Administration (OSHA), over 11% of traditional forklifts are likely to be involved in ...